Home LiteratureArticle Details
PMID: 9666808 Published · ppublish English Journal Article

The proportion of clonal divisions varies in different hematologic malignancies. The United Kingdom Cancer Cytogenetics Group (UKCCG) [corrected].

Cancer genetics and cytogenetics ·Vol. 104 ·No. 2 ·1998-07-15 ·Pages 139-45

Swansbury GJ

Abstract

The detection of clones by conventional cytogenetic studies in diagnostic hematoncology is heavily subject to the effects of many biological and laboratory factors, one of which is the number of divisions analyzed. Data from 20 laboratories were combined to get an impression of the true frequency of clonal divisions for comparison with the theoretical models that have been previously used to set laboratory policies. This study showed that low-percentage clones were more common in the myelodysplastic syndromes and that high-percentage clones were more common in acute myeloid leukemia than in acute lymphoblastic leukemia (ALL), although the clone detection rate in ALLs is higher. The inference is that the putative diagnosis should be taken into account when deciding how many divisions to analyze before concluding that no detectable clone is present.

MeSH Terms
Cell Division Chromosome Aberrations Clone Cells Hematologic Neoplasms/genetics,pathology Humans Models, Genetic
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Swansbury G J
Academic Department of Haematology and Cytogenetics, Royal Marsden NHS Trust, Sutton, Surrey, United Kingdom.
Article Info
Journal
Cancer genetics and cytogenetics
Abbr.
Cancer Genet Cytogenet
ISSN
0165-4608
Published
1998-07-15
Pages
139-45
Language
English
Region
United States
NLM ID
7909240
Subset
IM
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com